Aim By understanding the reasons for delays in adjuvant chemotherapy (AC) after colonic resection, there is the potential to improve patient outcome. The aim of this study is to determine the extent and impact of complications after hospital discharge on delays to AC.
Introduction
Adjuvant chemotherapy (AC) following resection for Stage III colon cancer has been shown to improve prognosis, with an absolute increase of 7% in overall 5-year survival [1] . Although there are no official guidelines regarding the timing of AC, multiple studies have found a delay beyond 8 weeks to be associated with a reduction in the benefit of treatment [2] [3] [4] .
Recent studies have suggested complications following resection may lead to a delay in AC [5] . However, these studies have concentrated on hospital data and have not considered complications after discharge, such as venothromboembolic events (VTEs) or wound infections. These are often managed in primary care and have the potential to delay treatment further. In addition, no study has investigated an association between complications and a delay in AC while confounding for the urgency of admission that led to the resection, co-morbidities and the type of surgical approach. It is unclear whether the impact of a delay in AC on overall survival is maintained after taking these factors into account.
The aim of this observational cohort study was to describe the patient factors and complications encountered in primary and secondary care associated with an increased risk of a delay in AC beyond 8 weeks and the impact on survival.
Method Data source
Data were derived from the Clinical Practice Research Datalink (CPRD), which provides primary care data for 8-10% of the UK population [6] and is considered accurate and representative of the whole population [7] . Internal criteria ensure the anonymized records are of an 'acceptable' standard [8] , and from practices with research-quality data. Individual patient records are linked to Hospital Episode Statistics (HES) and the Office for National Statistics (ONS) cause of mortality, making it is possible to identify the clinical events of interest along the patient pathway. Data were provided under protocol 13_078 with ethical approval from CPRD and Independent Scientific Advisory Committee (ISAC).
Patient selection
A patient was deemed to have undergone a resection for colon cancer if a relevant procedure was recorded in the linked HES dataset based on OPCS Classification of Interventions and Procedures (OPCS) coding (Appendix S1 in the online Supporting Information) during the same admission as an ICD-10 (International Statistical Classification of Diseases and Related Health Problems, 10th Revision) diagnosis of colon cancer (Appendix S2) between 1 April 2000 and 1 April 2011. From this population, the study cohort was selected as those with a HES episode for chemotherapy (Appendix S3) within 16 weeks of the resection. A threshold of 16 weeks has previously been used, as it is unlikely AC treatment beyond this is for curative intent [9] . Patients were excluded if they were under 18 years of age, had an ICD code indicating metastatic disease (Appendix S4) recorded within 28 days of the resection, or an alternative cancer diagnosis within 3 years before the resection.
Defining the start of adjuvant chemotherapy
Patients in the early AC group included those with their first AC episode within 8 weeks of the resection; the remainder formed the late group. Differences between the early and late groups were compared for age (under 60, 60-75, over 75), gender, smoking history, Charlson score (zero, one or more), year of the procedure (2000-2003, 2004-2007, 2008-2011) , surgical access (laparoscopic or open), admission type for resection (emergency or elective), stoma at resection and a complication following a resection.
Study variables
Charlson score was calculated from 3 years of HES data preceding the resection [10] . A laparoscopic resection was defined by the OPCS code (Appendix S1) at the time of the resection. Conversion to open was considered as open surgery rather than laparoscopic. Stoma at the index procedure was defined as a Hartmann's procedure or the relevant OPCS code. The rate of stoma reversal (OPCS-G75.3 or H15.4) before the start of chemotherapy, and within 18 months of the original resection was also compared between the two groups.
Complications were defined as re-operation (Appendix S5), bowel obstruction without operation, wound infection or systemic complications (acute renal failure, myocardial infarction, cerebrovascular event, pneumonia). These complications were searched in HES in the interval between resection and start of AC, while the CPRD was used to identify pneumonia, VTEs or wound complications following discharge. A patient may have experienced more than one complication. These complications were included as they were considered relevant causes for a delay in AC.
Statistical analysis
The chi-square test was used to investigate differences in categorical variables between the two AC groups. These variables were included in a binary logistic regression model to determine the risk of a delay in AC. Complications were considered as either present or absent. Clinically relevant two-way interactions were entered individually with the main effects model to determine whether they produced a significant change. All such interactions were then entered together into the model and removed step-wise if found to be nonsignificant. The only significant interaction included in the model was between the type of admission and surgical access.
A Cox proportional hazards model identified whether there was a difference in mortality between the two AC groups, while taking into consideration the aforementioned patient and surgery variables. Survival was calculated from the start of AC to the date of death in ONS. No time-dependent factors were found that would have violated the proportional hazards assumption. Smoking history and a delay in AC was the only significant interaction and this included in the full model. Kaplan-Meier curves described the difference in survival function between the early and late AC groups.
Robust standard errors were constructed that accounted for heteroscedasticity. All analyses were carried out using SPSS (IBM, v.22), with significance taken at P < 0.05.
Results
A total of 7501 patients had a colon cancer resection between 2000 and 2011. Of these 1266 (16.9%) underwent AC within 16 weeks. The median time to the first treatment was 8.1 weeks (interquartile range 6.7-10.1 weeks). The earliest was at 2.3 weeks (Fig. 1) , with the latest as per the criterion of 16 weeks. A total of 598 patients (47.2%) started their AC within 8 weeks of the resection.
Summary statistics
A higher proportion of patients over 75 (59.9%) experienced a delay in treatment compared with those under 60 (50.1%) and aged 60-75 (52.0%), although this did not reach significance (P = 0.067) ( Table 1) . A significantly higher percentage of patients receiving AC late had a stoma at the time of the resection (65.5% P < 0.005). No difference was found between the two groups in terms of gender, year of resection or Charlson score, surgical access (laparoscopy 46.8% early vs 53.2% 
Complications
From the CPRD, 59 patients suffered a wound infection managed conservatively, of whom 57 (96.6%) were not noted in HES ( Table 2) . None of the patients who experienced a delay in AC and had a wound infection in CPRD (n = 37) had this complication recorded in HES. A further six cases of VTE were in CPRD but not described in HES. There were no cases of pneumonia in CPRD. A significantly higher percentage from the late group underwent a re-operation compared with the early group (3.3% vs 7.0% P = 0.005). Although there was no significant difference in the rate of wound infection in the HES data between the two AC groups, this complication was significantly higher in the late AC group (5.5% vs 3.3% P = 0.040) when using CPRD.
Using HES alone, 88 (14.7%) patients from the early AC group compared with 142 (21.3%) in the late AC group experienced a complication. By also including CPRD data, the number of patients identified increased by 24% for both groups.
Regression analysis for delays
The risk of late AC treatment increased significantly following a complication (OR 1.53, 95% CI 1.16-2.03, P = 0.003) ( Table 3 ). Patients aged under 60 were significantly less likely to experience a delay in AC compared with those over 75 (OR 0.65, 95% CI 0.46-0.93, P < 0.019), while there was no difference compared with the 60-75 year age group. Smoking (OR 1.60, 95% CI 1.08-2.35, P = 0.018) or a stoma at the index operation (OR 1.79, 95% CI 1.26-2.52, P = 0.001) increased the risk of a delay. Gender, the year of resection, laparoscopy or the type of admission did not alter the odds of a delay in AC.
Impact on survival
A significantly higher proportion of patients in the late AC group had died by the end of ONS coverage (32.9% vs 27.3%). Compared with patients who received AC early; those in the late group were associated with an increase in the risk of death [hazard ratio (HR) 1.44, 95% CI 1.16-1.79, P = 0.001], as were smokers (HR 2.26, 95% CI 1.41-3.64).
Undergoing a laparoscopic rather than an open resection (HR 0.84, 95% CI 0.56-1.27, P = 0.414) or experiencing a complication (HR 1.15, 95% CI 0.89-1.48, P = 0.295) did not significantly alter prognosis. However, an emergency resection significantly increased the risk of death (by 59%) (95% CI 1.28-1.98, P < 0.0005) compared with those who underwent an elective procedure. A resection between 2008 and 2011 Figure 2 suggests that AC within 8 weeks was associated with a relative increase in survival by 12.3% at 5 years (65% in the early treatment group vs 73% in the late treatment group).
Discussion Summary
The aim of this study was to determine the factors associated with a delay in initiating AC following resection for colonic cancer, and their impact on long-term prognosis. The CPRD was shown to include a proportion of wound infections and VTEs that were not noted in HES, suggesting that secondary care data are insufficient to describe the extent of complications experienced by patients before AC treatment. Smoking history, stoma at the time of resection and older age were associated with a delay in AC after 8 weeks. By definition, all the patients in this study survived to receive AC. Therefore, although complications were associated with a delay in AC, they did not independently affect survival.
Comparison with previous studies
This is the first study to use routinely collected national primary and secondary care data to identify a combination of factors that are associated with a delay in AC. The CPRD has been validated as being reliable in terms of patient demographics, diagnoses and prescription data [6] .
AC following colonic resection can be considered a marker of the standard of treatment [11] . No study has shown a poorer outcome if the treatment is started 'too early', but starting AC after 12 weeks has been shown to have little benefit [12] . The findings of an improvement of 12.3% in survival at 5 years for patients treated within 8 weeks are similar to those of previous studies [2, 9] .
Although it may be expected that complications are associated with a delay in the first episode of AC, we were able to describe in detail complications from both primary and secondary care. For example, in previous studies postoperative hospital stay has been used as a surrogate marker for complications managed conservatively [13] , but data for conservative treatment of bowel obstruction have not previously been published. In our study, this was the most common complication (9.6%, n = 122), and in the majority is likely to represent postoperative ileus. From the CPRD we identified an extra 56 patients as having suffered a complication, with the majority being wound infections. Some 5.3% of all patients underwent a re-operation, with a significantly higher proportion in the delayed AC group (7.0%, n = 47). The overall re-operation rate was lower than the 14% reported by van der Geest et al [14] . but similar to the 5.6% reported by Nachiappan et al. This reflects the different data sources: van der Geest et al. used medical records, whereas the latter group used HES, similar to our study.
In addition to complications, a stoma at the initial operation was a risk factor for delays. However from HES it is not possible to ascertain with certainty whether the stoma was a permanent or temporary bowel discontinuation. The lack of detail also precludes differentiating whether the higher proportion of reversals before AC in the delayed group were because of high output or a pre-operative plan to reverse before AC. The lower proportion of patients from the delayed AC group undergoing a reversal within 18 months may reflect more end stomas or the patient was no longer suitable for another procedure. Interestingly smoking was found to be an independent risk factor for a delay in AC. An interaction between smoking and complications or Charlson score was not demonstrated to explain this finding. A surgeon may decide to use a minimally invasive approach to reduce recovery time [15] . However, this study demonstrates there is no difference in using laparoscopy or open surgery in terms of reducing post-operative treatment delays after adjusting for complications.
Our findings suggest that patients who manage to start AC treatment despite experiencing a complication are no longer at risk of increased mortality due to the complication. This is similar to results of previous studies by Tevis et al [5] and Nachiappan et al [16] . As expected, a smoking history [17] or an emergency admission [18] Between these periods our data demonstrate a reduction in the rate of emergency resections perhaps due to the NICE referral guidelines and/or screening. This could also reflect a change in practice to treat high-risk Stage II colon cancer with adjuvant chemotherapy, or the addition of oxaliplatin in chemotherapy regimens [19] .
Strengths and limitations
This is the first study to use linked data from the CPRD as the source, and so we have been able to consider postdischarge complications leading to delays in treatment. The number of colon cancer cases identified through our method compares well with the National Bowel Cancer Audit [20] . In 2011, the latter reported that 17 161 patients underwent a colonic resection. From our data in 2010, 1242 (7.2%) had a resection. This is close to the 8% coverage of the national population by the CPRD. However, the proportion of patients receiving AC could be considered low, as previous studies have shown that almost 20% of colon cancer patients receive such treatment [1] . This is probably related to the completeness of chemotherapy coding in HES, which has improved in latter years.
As the accuracy of CPRD [21] and HES [22] in terms of complications compared to patients notes is unclear, it is not possible to conclude with confidence that wound infections recorded in CPRD and not in HES were de novo diagnoses in primary care or missing cases. The accuracy of these two datasets would have improved in the latter years. We are unable to ascertain the percentage of patients that had a delay in treatment due to administrative issues unrelated to the resection, such as unavailability of services, or did not complete the treatment regimen. The latter has been shown to effect overall survival [23] . As we could not include stage, we assumed the presence of AC episodes, and the exclusion of patients with metastases was sufficient to identify patients receiving AC for curative purposes.
Conclusion
A reliance on secondary care data alone will underestimate the rate of complications following colonic resection. After adjusting for potential confounders, such as type of surgical access and emergency admission, this study demonstrated that complications, identified in primary care and in the hospital, are associated with a delay in AC following resection for colon cancer. The significant reduction in survival following a delay in AC should encourage clinicians to ensure that all possible steps are taken to reduce complications and manage them effectively.
